Our Current Studies include:
Multidisciplinary Vulvodynia Program (MVP) outcomes for women with provoked vestibulodynia
The purpose of this study is to determine the efficacy of the 11- session MVP intervention for decreasing PVD symptoms, improving women’s pain intensity, mood and sexual function and reducing their sexual distress and pain catastrophizing. Study participants will be asked to complete questionnaires at 4 time points: prior to participating in the MVP, immediately after the conclusion of the MVP, and again 6 & 18 months later.
MVP outcomes for women over 45 years of age
The purpose of the MVP 45+ study is to document if and how participation in a 2-session psychoeducational MVP intervention benefits peri- and post-menopausal women (women over the age of 45). Study participants will be asked to complete questionnaires relating to pain intensity, mood, sexual function, sexual distress and pain catastrophizing. Questionnaires will be administered at 4 time points: prior to attending the psychoeducational seminars, immediately after the conclusion of the seminars, and again at 6 & 18 months post seminars.
Vulvar disease quality of life (VDQoL) study:
The goal of this study is to complete the first phase of the development of a vulvar disease-specific quality of life measure. The main objectives are to conduct interviews with physician experts; and (2) conduct interviews with women about living with a vulvar skin dermatosis. This study is the first step in developing a health-related quality of life instrument specifically for women with vulvar diseases. The results will establish content for a vulvar disease-specific quality of life instrument. If you are interested in participating in this study, please contact study Coordinator Laura Sze at Laura.Sze@vch.ca.
Systematic review of vulvodynia research:
The objectives of this study are to systematically evaluate the literature regarding treatment outcomes for vulvodynia. Specifically, to (a) identify reported outcomes of vulvodynia treatments; (b) categorize the outcomes based on the appropriateness of content; and (c) analyze descriptions of patient adherence and treatment success.
Anal screening study for patients with recurrent vulvar intra-epithelial neoplasia (VIN)
The purpose of this study is to determine the number of women with recurrent VIN who have abnormalities to the cells of the anal canal. The information gained from this study will help to determine if women with VIN may benefit from anal cancer screening. Participants will be asked to fill out two questionnaires, consent to an anal Pap smear and a digital rectal exam. Pap smears will be followed up according to results. Inclusion criteria is women between the ages of 30 to 70 that have had two biopsy diagnoses of VIN2/3 in the past 5 years.
If you are interested in supporting the research at our Centre, please direct donations to the BC Centre for Vulvar Health through the Vancouver and UBC Hospital Foundation.
How Can You Donate to the B.C. Centre for Vulvar Health?
The BCCVH accepts donations through the VGH & UBC Hospital Foundation – a registered charity that raises funds for much-needed medical equipment, world-class research and improvements to patient care. The Foundation receives donations for a number of causes but any gifts specifically designated for the BCCVH will be directed towards our program.
To make a secure on-line donation to the B.C. Centre for Vulvar Health, click here.